Cargando…
Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
Anthracyclines are commonly used to treat childhood leukemias and lymphomas, as well as other malignancies, leading to a growing population of long-term childhood cancer survivors. However, their use is limited by cardiotoxicity, increasing survivors' vulnerability to treatment-related complica...
Autores principales: | Franco, Vivian I., Henkel, Jacqueline M., Miller, Tracie L., Lipshultz, Steven E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038566/ https://www.ncbi.nlm.nih.gov/pubmed/21331374 http://dx.doi.org/10.4061/2011/134679 |
Ejemplares similares
-
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019) -
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
por: Long, Treya M., et al.
Publicado: (2019) -
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
por: Li, Vivian Wing-yi, et al.
Publicado: (2018) -
Cardiac Events in Childhood Cancer Survivors Treated with Anthracyclines: The Value of Previous Myocardial Strain Measurement
por: Pourier, Milanthy, et al.
Publicado: (2022) -
Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015)